Differences in subcortical brain volumes among patients with schizophrenia and bipolar disorder and healthy controls

K Ohi, M Ishibashi, K Torii, M Hashimoto, Y Yano… - Journal of Psychiatry and …, 2022 - jpn.ca
Background: Patients with schizophrenia and bipolar disorder have an overlapping polygenic
architecture and clinical similarities, although the 2 disorders are distinct diagnoses with …

High amplification of PVT1 and MYC predict favorable prognosis in early ovarian carcinoma

…, K Yamamoto, D Nogawa, M Inoue, S Ishibashi… - … -Research and Practice, 2020 - Elsevier
Introduction The objective of this study was to evaluate the status of MYC and PVT1, which
are frequently amplified in malignant tumors, and to assess their biological features according …

[HTML][HTML] Indirect CRISPR screening with photoconversion revealed key factors of drug resistance with cell–cell interactions

K Sugita, I Onishi, R Nakayama, S Ishibashi… - Communications …, 2023 - nature.com
Comprehensive screenings to clarify indirect cell–cell interactions, such as those in the tumor
microenvironment, especially comprehensive assessments of supporting cells’ effects, are …

Angiogenic mediators of the angiopoietin system are highly expressed by CD10‐positive lymphoma cells in angioimmunoblastic T‐cell lymphoma

…, K Yamamoto, F Ishibashi… - British journal of …, 2009 - Wiley Online Library
Angioimmunoblastic T‐cell lymphoma (AILT) is a malignant disease of peripheral T‐cell origin
that is characterized by a prominent proliferation of high endothelial venules in the lymph …

Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia

S Kirimura, M Kurata, Y Nakagawa, I Onishi… - Pathology, 2016 - Elsevier
… We thank Ms Miori Inoue and Ms Sachiko Ishibashi from the Department of Comprehensive
Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental …

Overexpression of MCM2 in myelodysplastic syndromes: association with bone marrow cell apoptosis and peripheral cytopenia

S Suzuki, M Kurata, S Abe, R Miyazawa… - … and molecular pathology, 2012 - Elsevier
Myelodysplastic syndromes (MDS) are characterized by proliferation and apoptosis of bone
marrow cells. Minichromosome maintenance protein (MCM) 2, which is known to be …

[PDF][PDF] Differential expression of ACINUS variants in bone marrow in myelodysplastic syndromes

N Miyamoto, M Kurata, T Nagiri, S Abe… - Int J Clin Exp …, 2017 - e-century.us
Hematopoietic cells in the bone marrow of myelodysplastic syndromes (MDS) exhibit a
complex pattern of cellular dynamics, showing active cellproliferation, as well as frequent …

Expression of multidrug resistance 1 gene in association with CXCL12 in chronic myelogenous leukaemia

I Onishi, Y Nakagawa, T Murayama, M Hidaka… - Pathology, 2014 - Elsevier
Even though the BCR-ABL tyrosine kinase inhibitor imatinib significantly improves the prognosis
of chronic myelogenous leukaemia (CML) patients, drug resistance is a major obstacle …

[HTML][HTML] CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes

S Abe-Suzuki, M Kurata, S Abe, I Onishi… - Laboratory …, 2014 - Elsevier
… We thank Ms Miori Inoue and Ms Sachiko Ishibashi for their technical assistance. This
work was supported in part by a grant-in-aid (No. 21590432) from the Ministry of Education, …

[HTML][HTML] Identification of the Factor That Leads Human Mesenchymal Stem Cell Lines into Decellularized Bone

A Koyanagi, I Onishi, K Muraoka, I Sato, S Sato… - Bioengineering, 2022 - mdpi.com
… The skillful technical assistance of Masumi Ikeda, Sachiko Ishibashi, and Miori Inoue is
gratefully acknowledged. The authors thank Novogene Japan KK and Keisuke Sugita for their …